0001209191-23-034992.txt : 20230607
0001209191-23-034992.hdr.sgml : 20230607
20230607142947
ACCESSION NUMBER: 0001209191-23-034992
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230607
DATE AS OF CHANGE: 20230607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abbott Matthew S
CENTRAL INDEX KEY: 0001786056
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36794
FILM NUMBER: 23998617
MAIL ADDRESS:
STREET 1: C/O THE CHEMOURS COMPANY
STREET 2: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemours Co
CENTRAL INDEX KEY: 0001627223
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
IRS NUMBER: 464845564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 302 773 1000
MAIL ADDRESS:
STREET 1: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Chemours Company, LLC
DATE OF NAME CHANGE: 20141205
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-06-06
0
0001627223
Chemours Co
CC
0001786056
Abbott Matthew S
C/O THE CHEMOURS COMPANY
1007 MARKET STREET
WILMINGTON
DE
19801
0
1
0
0
SVP, Chief Enterprise Transfor
Common Stock
29869.1243
D
Stock Option (Right to Buy)
34.84
2033-03-01
Common Stock
4964
D
Stock Option (Right to Buy)
25.98
2032-03-01
Common Stock
12740
D
Stock Option (Right to Buy)
24.01
2031-03-01
Common Stock
12269
D
Stock Option (Right to Buy)
14.43
2030-03-02
Common Stock
8912
D
Stock Option (Right to Buy)
38.02
2029-03-01
Common Stock
6097
D
Stock Option (Right to Buy)
48.53
2028-03-01
Common Stock
4136
D
Stock Option (Right to Buy)
34.72
2027-03-01
Common Stock
5441
D
Performance Stock Option (Right to Buy)
38.32
2033-03-01
Common Stock
5093
D
Includes directly owned shares, restricted stock units and dividend equivalent units.
Options vest in three equal installments beginning on March 1, 2024.
Options vest in three equal installments beginning on March 1, 2023.
Options vest in three equal installments beginning on March 1, 2022.
Options are fully vested.
Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
/s/ Pauletta Brown, Attorney-in-Fact
2023-06-07